Business Services Industry

Government to Work to Stop Distribution of Bad Information from Biotech Firms.

Knight Ridder/Tribune Business News, February, 2004

By Terri Somers, The San Diego Union-Tribune Knight Ridder/Tribune Business News

Feb. 5--The Securities and Exchange Commission and the Food and Drug Administration will unveil a plan today to work together to crack down on the dissemination of false and misleading information about biotechnology companies.

The plan is intended to improve information coordination between the agencies in cases in which drug companies or other businesses regulated by the FDA release false or misleading statements about a product's reviews by the FDA, government sources familiar with the plan told the Associated Press.

FDA reviews can have a powerful impact on stock prices of companies seeking approval for their products, as seen in the ImClone case that...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement